Search for: "Merck & Company, Inc." Results 241 - 260 of 447
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Dec 2009, 9:09 pm by ipdeals
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
24 Oct 2012, 10:02 am by Tom Lamb
The NuvaRing birth control product was initially approved by the FDA in October 2001, when Organon USA Inc. was the responsible drug company. [read post]
28 May 2010, 8:52 am by law shucks
’s $5.1 billion bid for Airgas Inc. [read post]
12 May 2015, 3:26 pm by James Galvin
Inc. 902641802 UBS Yield Optimization Securities with Contingent Protection linked to McDonald’s Corp. 902641851 UBS Yield Optimization Securities with Contingent Protection linked to Schlumberger, Ltd. 902641869 UBS Yield Optimization Securities with Contingent Protection linked to Oracle Corp. 902641877 UBS Yield Optimization Securities with Contingent Protection linked to Dell Inc. 902641885 UBS Yield Optimization Securities with Contingent Protection linked to AT&T… [read post]
15 Jun 2011, 4:56 am by Marie Louise
Merck & Co Inc v Deutsches Patent- und Markenamt (The SPC blog) (The SPC blog) (The SPC blog) Monaco: Monaco, France and SPCs (The SPC blog) US: Supreme Court clarifies ownership rights in federally funded inventions under the Bayh-Dole Act: Stanford v. [read post]
21 Dec 2010, 9:32 am
Those affairs included 11,000 shares of stock in the pharmaceutical company Merck, which had a value of $985,000 in 2001. [read post]
23 Apr 2010, 8:20 am by Press Releases
” Expected to attend are IP leaders from BP America Inc., Merck & Co., Inc., Bose, Brigham Young University, Cornell University, Stanford University, Duke University, Georgetown University, GlaxoSmithKline, Honeywell, Harvard University, Johnson & Johnson, Kauffman Foundation, Lockheed Martin, Massachusetts Institute of Technology (MIT), Mayo Clinic, Ortho-McNeil Pharmaceuticals Inc., Rutgers, Syngenta Biotechnology, Scripps Research Institute, U.S. [read post]
24 Feb 2011, 9:02 am by Lawrence B. Ebert
Life Sciences Center =MLSC]may now look to claw back the financial awards it gave to eight companies because they haven’t met a 70 percent job-creation threshold stipulated by the MLSC’s Tax Incentive Program, according to a report from the agency.Those companies are Facet Solutions Inc., Interlace Medical Inc., Morgan Advanced Ceramics, TEI Biosciences Inc., Alnylam Pharmaceuticals, Constellation Pharmaceuticals, Cubist Pharmaceuticals and… [read post]
4 Jun 2008, 3:44 pm
Inc. and Pfizer Inc., but there is also an unintended downside. [read post]